Breaking News Instant updates and real-time market news.

NEXT

NextDecade

$4.94 /

+0.05 (+1.02%)

, ENB

Enbridge

$42.00 /

+0.1635 (+0.39%)

19:02
02/13/20
02/13
19:02
02/13/20
19:02

Enbridge to acquire Rio Bravo Pipeline Company from NextDecade

NextDecade Corporation (NEXT) and Enbridge Inc. (ENB) announced that they have entered into a definitive agreement whereby Enbridge will acquire Rio Bravo Pipeline Company, LLC from NextDecade for a cash purchase price not to exceed $25M, with $15M paid at closing and the balance paid upon NextDecade's reaching a positive final investment decision on its Rio Grande LNG export facility in the Port of Brownsville, Texas. Upon closing of the transaction, Enbridge will own one hundred percent of RBPL and assume all responsibility for the development, financing, construction, and operations of the Rio Bravo Pipeline. NextDecade will continue to be responsible for the development, financing, construction, and operations of its Rio Grande LNG export facility. In addition, Enbridge and NextDecade have negotiated a precedent agreement, to be executed at closing, whereby NextDecade will retain its rights to the natural gas firm transportation capacity on the Rio Bravo Pipeline for a term of at least twenty years to supply NextDecade's Rio Grande LNG export facility. The Rio Bravo Pipeline is designed to transport up to 4.5B cubic feet per day of natural gas from the Agua Dulce supply area to NextDecade's Rio Grande LNG project in Brownsville, Texas. In November 2019, the Federal Energy Regulatory Commission issued an order authorizing the siting, construction, and operation of NextDecade's Rio Grande LNG project and the Rio Bravo Pipeline. In January 2020, FERC issued a final order on rehearing for the Rio Grande LNG project and the Rio Bravo Pipeline. The agreement has been approved by the Boards of Directors of both companies. Subject to the satisfaction of certain conditions, the transaction is expected to close in the first quarter of 2020.

NEXT

NextDecade

$4.94 /

+0.05 (+1.02%)

ENB

Enbridge

$42.00 /

+0.1635 (+0.39%)

  • 14

    Feb

  • 01

    Mar

NEXT NextDecade
$4.94 /

+0.05 (+1.02%)

09/20/19 Morgan Stanley
NextDecade initiated with an Underweight at Morgan Stanley
09/17/19
NextDecade initiated with an Outperform at Evercore ISI
09/17/19 Evercore ISI
NextDecade initiated with an Outperform at Evercore ISI
05/13/19 Gabelli
NextDecade initiated with a Buy at Gabelli
ENB Enbridge
$42.00 /

+0.1635 (+0.39%)

01/06/20 Morgan Stanley
Enbridge initiated with an Equal Weight at Morgan Stanley
12/18/19 BofA
Enbridge reinstated with a Buy at BofA/Merrill
12/05/19 Jefferies
Enbridge initiated with a Hold at Jefferies
12/04/19
Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Hot Stocks
Akamai, AT&T extend business relationship through 2023 » 06:33
09/22/20
09/22
06:33
09/22/20
06:33
AKAM

Akamai

$110.18 /

+0.99 (+0.91%)

, T

AT&T

$28.64 /

-0.28 (-0.97%)

Akamai (AKAM) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AKAM Akamai
$110.18 /

+0.99 (+0.91%)

T AT&T
$28.64 /

-0.28 (-0.97%)

AKAM Akamai
$110.18 /

+0.99 (+0.91%)

07/29/20 Craig-Hallum
Akamai price target raised to $130 from $120 at Craig-Hallum
07/29/20 Raymond James
Akamai price target raised to $117 from $110 at Raymond James
07/29/20 Credit Suisse
Akamai price target raised to $105 from $95 at Credit Suisse
07/29/20 B. Riley FBR
Akamai price target raised to $130 from $125 at B. Riley FBR
T AT&T
$28.64 /

-0.28 (-0.97%)

08/31/20
Fly Intel: Top five analyst downgrades
08/31/20 Scotiabank
Scotiabank downgrades AT&T to Underperform on spectrum costs, share losses
08/31/20 Scotiabank
AT&T downgraded to Underperform from Sector Perform at Scotiabank
07/24/20 RBC Capital
AT&T price target lowered to $32 from $38 at RBC Capital
AKAM Akamai
$110.18 /

+0.99 (+0.91%)

T AT&T
$28.64 /

-0.28 (-0.97%)

AKAM Akamai
$110.18 /

+0.99 (+0.91%)

T AT&T
$28.64 /

-0.28 (-0.97%)

AKAM Akamai
$110.18 /

+0.99 (+0.91%)

T AT&T
$28.64 /

-0.28 (-0.97%)

AKAM Akamai
$110.18 /

+0.99 (+0.91%)

T AT&T
$28.64 /

-0.28 (-0.97%)

Downgrade
Hikma Pharmaceuticals downgraded to Equal Weight from Overweight at Morgan Stanley » 06:32
09/22/20
09/22
06:32
09/22/20
06:32
HKMPF

Hikma Pharmaceuticals

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HKMPF Hikma Pharmaceuticals
$0.00 /

+ (+0.00%)

HKMPF Hikma Pharmaceuticals
$0.00 /

+ (+0.00%)

05:18 Today Morgan Stanley
Hikma downgraded to Equal Weight from Overweight at Morgan Stanley
09/08/20 Goldman Sachs
Hikma Pharmaceuticals upgraded to Buy from Neutral at Goldman Sachs
09/04/20 Goldman Sachs
Goldman sees Amarin investor focus shifting to 'significant' Europe opportunity
09/04/20 Barclays
Hikma Pharmaceuticals upgraded to Overweight from Equal Weight at Barclays
HKMPF Hikma Pharmaceuticals
$0.00 /

+ (+0.00%)

Recommendations
Toll Brothers price target raised to $45 from $43 at Barclays » 06:31
09/22/20
09/22
06:31
09/22/20
06:31
TOL

Toll Brothers

$47.03 /

+2.295 (+5.13%)

Barclays analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TOL Toll Brothers
$47.03 /

+2.295 (+5.13%)

TOL Toll Brothers
$47.03 /

+2.295 (+5.13%)

08/27/20 BTIG
Toll Brothers price target raised to $36 from $27 at BTIG
08/27/20 Barclays
Toll Brothers price target raised to $43 from $29 at Barclays
08/26/20 Wedbush
Toll Brothers price target raised to $53 from $45 at Wedbush
08/21/20 Wells Fargo
Toll Brothers price target raised to $44 from $34 at Wells Fargo
TOL Toll Brothers
$47.03 /

+2.295 (+5.13%)

TOL Toll Brothers
$47.03 /

+2.295 (+5.13%)

TOL Toll Brothers
$47.03 /

+2.295 (+5.13%)

TOL Toll Brothers
$47.03 /

+2.295 (+5.13%)

Periodicals
Alibaba-backed ZTO Express seen raising $1.3B from Hong Kong listing, DJ reports » 06:29
09/22/20
09/22
06:29
09/22/20
06:29
ZTO

ZTO Express

$28.68 /

-1.98 (-6.46%)

, BABA

Alibaba

$273.83 /

+1.4 (+0.51%)

Alibaba (BABA)-backed ZTO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ZTO ZTO Express
$28.68 /

-1.98 (-6.46%)

BABA Alibaba
$273.83 /

+1.4 (+0.51%)

ZTO ZTO Express
$28.68 /

-1.98 (-6.46%)

09/18/20 JPMorgan
ZTO Express initiated with an Overweight at JPMorgan
07/13/20 BOCOM
ZTO Express upgraded to Buy from Neutral at BOCOM
05/22/20 JPMorgan
ZTO Express downgraded to Neutral from Overweight at JPMorgan
05/22/20 Daiwa
ZTO Express downgraded to Hold from Buyat Daiwa
BABA Alibaba
$273.83 /

+1.4 (+0.51%)

08/26/20 Argus
Alibaba price target raised to $330 from $260 at Argus
08/24/20 Susquehanna
Alibaba price target raised to $350 from $275 at Susquehanna
08/24/20 Barclays
Alibaba price target raised to $320 from $300 at Barclays
08/21/20 Truist
Alibaba price target raised to $285 from $242 at Truist
ZTO ZTO Express
$28.68 /

-1.98 (-6.46%)

BABA Alibaba
$273.83 /

+1.4 (+0.51%)

BABA Alibaba
$273.83 /

+1.4 (+0.51%)

ZTO ZTO Express
$28.68 /

-1.98 (-6.46%)

BABA Alibaba
$273.83 /

+1.4 (+0.51%)

BABA Alibaba
$273.83 /

+1.4 (+0.51%)

Initiation
Fevertree Drinks initiated with an Equal Weight at Morgan Stanley » 06:29
09/22/20
09/22
06:29
09/22/20
06:29
FQVTF

Fevertree Drinks

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FQVTF Fevertree Drinks
$0.00 /

+ (+0.00%)

09/17/20 Berenberg
Fevertree Drinks price target raised to 2,500 GBp from 2,350 GBp at Berenberg
07/16/20 JPMorgan
Fevertree Drinks downgraded to Underweight from Neutral at JPMorgan
07/13/20 Barclays
Fevertree Drinks initiated with an Overweight at Barclays
06/22/20 RBC Capital
Fevertree Drinks upgraded to Outperform from Sector Perform at RBC Capital
Recommendations
Centene price target lowered to $72 from $84 at Barclays » 06:29
09/22/20
09/22
06:29
09/22/20
06:29
CNC

Centene

/

+

Barclays analyst Steve…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CNC Centene
/

+

CNC Centene
/

+

09/21/20 Citi
Citi sees ACA remaining law despite Ginsburg death
08/26/20 JPMorgan
Biden policies 'current overhang' on Managed Care sector, says JPMorgan
08/17/20
Loeb's Third Point buys Alibaba, makes a top holding, during second quarter
07/29/20 Deutsche Bank
Centene price target raised to $87 from $80 at Deutsche Bank
CNC Centene
/

+

CNC Centene
/

+

CNC Centene
/

+

CNC Centene
/

+

Initiation
Coca-Cola HBC initiated with an Overweight at Morgan Stanley » 06:28
09/22/20
09/22
06:28
09/22/20
06:28
CCHGY

Coca-Cola HBC

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CCHGY Coca-Cola HBC
$0.00 /

+ (+0.00%)

08/07/20 JPMorgan
Coca-Cola HBC price target raised to 2,525 GBp from 2,325 GBp at JPMorgan
08/06/20 Credit Suisse
Coca-Cola HBC price target raised to 2,550 GBp from 2,400 GBp at Credit Suisse
08/06/20 Societe Generale
Coca-Cola HBC upgraded to Hold from Sell at Societe Generale
07/09/20 UBS
Coca-Cola HBC price target raised to 2,200 GBp from 2,100 GBp at UBS
Initiation
Britvic initiated with an Overweight at Morgan Stanley » 06:27
09/22/20
09/22
06:27
09/22/20
06:27
BTVCY

Britvic

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTVCY Britvic
$0.00 /

+ (+0.00%)

07/29/20 UBS
Britvic price target raised to 880 GBp from 840 GBp at UBS
07/09/20 UBS
Britvic price target raised to 840 GBp from 750 GBp at UBS
05/06/20 JPMorgan
Britvic price target lowered to 850 GBp from 875 GBp at JPMorgan
04/29/20 Berenberg
Britvic price target lowered to 900 GBp from 1,060 GBp at Berenberg
Upgrade
Halkbank upgraded to Neutral from Underweight at JPMorgan » 06:26
09/22/20
09/22
06:26
09/22/20
06:26
THBIY

Halkbank

$0.00 /

+ (+0.00%)

JPMorgan analyst Samuel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
THBIY Halkbank
$0.00 /

+ (+0.00%)

07/16/20 JPMorgan
Halkbank price target raised to TRY 8 from TRY 6 at JPMorgan
05/22/20 JPMorgan
Halkbank price target raised to TRY 6 from TRY 5 at JPMorgan
Upgrade
Five Prime upgraded to Buy from Neutral at Guggenheim » 06:23
09/22/20
09/22
06:23
09/22/20
06:23
FPRX

Five Prime

$3.82 /

-0.2 (-4.98%)

Guggenheim analyst Etzer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FPRX Five Prime
$3.82 /

-0.2 (-4.98%)

FPRX Five Prime
$3.82 /

-0.2 (-4.98%)

06/22/20 Wedbush
Five Prime upgraded to Outperform from Neutral at Wedbush
06/22/20 Wedbush
Five Prime upgraded to Outperform from Neutral at Wedbush
02/28/20 JPMorgan
Five Prime downgraded to Underweight from Neutral at JPMorgan
02/28/20 JPMorgan
Five Prime downgraded to Underweight from Neutral at JPMorgan
FPRX Five Prime
$3.82 /

-0.2 (-4.98%)

Upgrade
British American Tobacco upgraded to Outperform at RBC Capital » 06:23
09/22/20
09/22
06:23
09/22/20
06:23
BTI

British American Tobacco

$33.82 /

-0.76 (-2.20%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTI British American Tobacco
$33.82 /

-0.76 (-2.20%)

BTI British American Tobacco
$33.82 /

-0.76 (-2.20%)

05:17 Today RBC Capital
British American upgraded to Outperform from Sector Perform at RBC Capital
09/02/20 Morgan Stanley
British American Tobacco price target lowered to 3,330 GBp at Morgan Stanley
08/10/20 JPMorgan
British American Tobacco price target lowered to 3,500 GBp at JPMorgan
08/05/20 Credit Suisse
British American Tobacco price target lowered to 3,930 GBp at Credit Suisse
BTI British American Tobacco
$33.82 /

-0.76 (-2.20%)

BTI British American Tobacco
$33.82 /

-0.76 (-2.20%)

Initiation
Seaport starts 'hard to resist' NextEra Energy with Buy, $229 target » 06:21
09/22/20
09/22
06:21
09/22/20
06:21
NEE

NextEra Energy

$276.29 /

-0.6 (-0.22%)

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

06:16 Today Seaport Global
NextEra Energy initiated with a Buy at Seaport Global
09/15/20 BMO Capital
NextEra Energy price target raised to $293 from $286 at BMO Capital
09/15/20 Wells Fargo
Wells Fargo upgrades NextEra Energy Partners on renewables outlook
09/04/20 Atlantic Equities
NextEra Energy initiated with an Overweight at Atlantic Equities
NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

Periodicals
Oracle: ByteDance won't have ownership in new TikTok Global, The Verge reports » 06:17
09/22/20
09/22
06:17
09/22/20
06:17
ORCL

Oracle

$60.85 /

+1.1 (+1.84%)

, WMT

Walmart

$137.04 /

+1.74 (+1.29%)

Oracle (ORCL) on Monday…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORCL Oracle
$60.85 /

+1.1 (+1.84%)

WMT Walmart
$137.04 /

+1.74 (+1.29%)

ORCL Oracle
$60.85 /

+1.1 (+1.84%)

09/21/20
Fly Intel: Top five analyst upgrades
09/21/20 William Blair
TikTok deal 'major coup' for Oracle, says William Blair
09/21/20 RBC Capital
Oracle upgraded to Outperform from Sector Perform at RBC Capital
09/21/20 RBC Capital
Oracle upgraded to Outperform from Sector Perform at RBC Capital
WMT Walmart
$137.04 /

+1.74 (+1.29%)

09/18/20 Cleveland Research
Walmart U.S. sales appear directionally better recently, says Cleveland Research
09/03/20 KeyBanc
Inovalon price target raised to $29 from $24 at KeyBanc
09/03/20 Bernstein
Walmart+ 'a bit rushed,' Walmart still best deal on grocery, says Bernstein
09/02/20 Morgan Stanley
Oak Street deal with Walmart an incremental opportunity, says Morgan Stanley
ORCL Oracle
$60.85 /

+1.1 (+1.84%)

WMT Walmart
$137.04 /

+1.74 (+1.29%)

ORCL Oracle
$60.85 /

+1.1 (+1.84%)

WMT Walmart
$137.04 /

+1.74 (+1.29%)

ORCL Oracle
$60.85 /

+1.1 (+1.84%)

WMT Walmart
$137.04 /

+1.74 (+1.29%)

ORCL Oracle
$60.85 /

+1.1 (+1.84%)

WMT Walmart
$137.04 /

+1.74 (+1.29%)

Recommendations
Illumina acquisition 'adds ambiguity' around valuation, says Citi » 06:17
09/22/20
09/22
06:17
09/22/20
06:17
ILMN

Illumina

$269.60 /

-25.695 (-8.70%)

Illumina's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

06:08 Today UBS
Illumina downgraded to Neutral from Buy at UBS
06:00 Today Stifel
Stifel downgrades Illumina to Hold after 'massively dilutive' deal
05:08 Today Stifel
Illumina downgraded to Hold from Buy at Stifel
05:02 Today Piper Sandler
Piper stays on sidelines after Illumina acquisition of Grail
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

Upgrade
Imperial Brands upgraded to Outperform from Sector Perform at RBC Capital » 06:17
09/22/20
09/22
06:17
09/22/20
06:17
IMBBY

Imperial Brands

$0.00 /

+ (+0.00%)

RBC Capital analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

05:17 Today RBC Capital
Imperial Brands upgraded to Outperform from Sector Perform at RBC Capital
09/04/20 JPMorgan
Imperial Brands upgraded to Overweight from Neutral at JPMorgan
07/09/20 UBS
Imperial Brands price target raised to 1,460 GBp from 1,200 GBp at UBS
07/07/20 Morgan Stanley
Imperial Brands price target lowered to 1,593 GBp at Morgan Stanley
IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

IMBBY Imperial Brands
$0.00 /

+ (+0.00%)

Initiation
NextEra Energy initiated with a Buy at Seaport Global » 06:16
09/22/20
09/22
06:16
09/22/20
06:16
NEE

NextEra Energy

$276.29 /

-0.6 (-0.22%)

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

09/15/20 BMO Capital
NextEra Energy price target raised to $293 from $286 at BMO Capital
09/15/20 Wells Fargo
Wells Fargo upgrades NextEra Energy Partners on renewables outlook
09/04/20 Atlantic Equities
NextEra Energy initiated with an Overweight at Atlantic Equities
09/01/20 Wells Fargo
NextEra Energy price target raised to $335 from $330 at Wells Fargo
NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

NEE NextEra Energy
$276.29 /

-0.6 (-0.22%)

Recommendations
Peloton shares have path to $175, says Roth Capital » 06:15
09/22/20
09/22
06:15
09/22/20
06:15
PTON

Peloton

$94.79 /

+5.005 (+5.57%)

Roth Capital analyst…

Roth Capital analyst George Kelly sees a path for Peloton Interactive shares to reach to $175 and he remains a buyer of the stock following the recent rally. Peloton closed Monday up $5.10 to $94.80. Sustained "rapid" revenue growth and "soon-to-come margin" expansion will give the stock support, Kelly tells investors in a research note. The analyst maintains a Buy rating on Peloton with a $125 price target. Several factors will drive sustained revenue growth in the coming years for Peloton, including continued at-home fitness momentum, new products, and lower prices, says Kelly. As a result, the analyst sees near-term upside and a $175 share price in four years.

ShowHide Related Items >><<
PTON Peloton
$94.79 /

+5.005 (+5.57%)

PTON Peloton
$94.79 /

+5.005 (+5.57%)

09/18/20 JPMorgan
Apple Fitness+ contribution will take time, says JPMorgan
09/16/20 Canaccord
Peloton on its way to connected fitness leadership, says Canaccord
09/16/20 Rosenblatt
Apple entrance not barrier to Peloton's growth, says Rosenblatt
09/16/20 Stifel
Peloton valuation framework supports 'four-year double,' says Stifel
PTON Peloton
$94.79 /

+5.005 (+5.57%)

  • 26
    Sep
PTON Peloton
$94.79 /

+5.005 (+5.57%)

PTON Peloton
$94.79 /

+5.005 (+5.57%)

PTON Peloton
$94.79 /

+5.005 (+5.57%)

Downgrade
BioLife Solutions downgraded to Perform from Outperform at Oppenheimer » 06:14
09/22/20
09/22
06:14
09/22/20
06:14
BLFS

BioLife Solutions

$26.39 /

-0.79 (-2.91%)

Oppenheimer analyst Suraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BLFS BioLife Solutions
$26.39 /

-0.79 (-2.91%)

BLFS BioLife Solutions
$26.39 /

-0.79 (-2.91%)

09/18/20 Cowen
BioLife Solutions initiated with an Outperform at Cowen
08/11/20 Benchmark
BioLife Solutions downgraded at Benchmark as shares reach price target
08/11/20 Benchmark
BioLife Solutions downgraded to Hold from Buy at Benchmark
07/10/20 B. Riley FBR
BioLife Solutions price target raised to $25.50 from $20 at B. Riley FBR
BLFS BioLife Solutions
$26.39 /

-0.79 (-2.91%)

  • 02
    Jul
BLFS BioLife Solutions
$26.39 /

-0.79 (-2.91%)

Downgrade
CytomX Therapeutics downgraded to Neutral from Buy at Guggenheim » 06:13
09/22/20
09/22
06:13
09/22/20
06:13
CTMX

CytomX Therapeutics

$6.94 /

-0.43 (-5.83%)

Guggenheim analyst Etzer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CTMX CytomX Therapeutics
$6.94 /

-0.43 (-5.83%)

CTMX CytomX Therapeutics
$6.94 /

-0.43 (-5.83%)

09/15/20 Citi
CytomX Therapeutics price target lowered to $8.50 from $11 at Citi
06/01/20 Jefferies
Jefferies 'underwhelmed' by CytomX presentations at ASCO, downgrades to Hold
06/01/20 Jefferies
CytomX Therapeutics downgraded to Hold from Buy at Jefferies
05/29/20 Piper Sandler
CytomX ASCO data sets point torwards Probody validation, says Piper Sandler
CTMX CytomX Therapeutics
$6.94 /

-0.43 (-5.83%)

CTMX CytomX Therapeutics
$6.94 /

-0.43 (-5.83%)

Downgrade
Eidos Therapeutics downgraded to Neutral from Buy at Guggenheim » 06:13
09/22/20
09/22
06:13
09/22/20
06:13
EIDX

Eidos Therapeutics

$47.62 /

-5.31 (-10.03%)

Guggenheim analyst Etzer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EIDX Eidos Therapeutics
$47.62 /

-5.31 (-10.03%)

EIDX Eidos Therapeutics
$47.62 /

-5.31 (-10.03%)

09/08/20 Citi
Eidos Therapeutics initiated with a Buy at Citi
06/05/20 Mizuho
HFA slide 'good' for BridgeBio, Eidos' AG10, says Mizuho
05/14/20 JPMorgan
Eidos Therapeutics downgraded to Neutral on timeline delays at JPMorgan
05/14/20 JPMorgan
Eidos Therapeutics downgraded to Neutral from Overweight at JPMorgan
EIDX Eidos Therapeutics
$47.62 /

-5.31 (-10.03%)

Upgrade
Portland General Electric upgraded to Buy from Neutral at Guggenheim » 06:13
09/22/20
09/22
06:13
09/22/20
06:13
POR

Portland General Electric

$34.24 /

-0.77 (-2.20%)

Guggenheim analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
POR Portland General Electric
$34.24 /

-0.77 (-2.20%)

POR Portland General Electric
$34.24 /

-0.77 (-2.20%)

09/21/20 Mizuho
Mizuho upgrades Portland General to Buy on valuation after selloff
09/21/20 Barclays
Portland General Electric upgraded to Equal Weight from Underweight at Barclays
09/21/20 Mizuho
Portland General Electric upgraded to Buy from Neutral at Mizuho
09/16/20 BofA
Portland General Electric upgraded to Buy from Neutral at BofA
POR Portland General Electric
$34.24 /

-0.77 (-2.20%)

POR Portland General Electric
$34.24 /

-0.77 (-2.20%)

Recommendations
Seattle Genetics price target raised to $200 from $185 at JMP Securities » 06:11
09/22/20
09/22
06:11
09/22/20
06:11
SGEN

Seattle Genetics

$178.83 /

-2.33 (-1.29%)

JMP Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SGEN Seattle Genetics
$178.83 /

-2.33 (-1.29%)

SGEN Seattle Genetics
$178.83 /

-2.33 (-1.29%)

09/21/20 Piper Sandler
Tisotumab data sets Seattle Genetics up for another approval, says Piper Sandler
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
09/15/20 RBC Capital
Seattle Genetics price target raised to $191 from $175 at RBC Capital
SGEN Seattle Genetics
$178.83 /

-2.33 (-1.29%)

SGEN Seattle Genetics
$178.83 /

-2.33 (-1.29%)

Initiation
CF Bankshares initiated with a Neutral at Piper Sandler » 06:10
09/22/20
09/22
06:10
09/22/20
06:10
CFBK

CF Bankshares

$11.68 /

+ (+0.00%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFBK CF Bankshares
$11.68 /

+ (+0.00%)

Downgrade
Illumina downgraded to Neutral from Buy at UBS » 06:08
09/22/20
09/22
06:08
09/22/20
06:08
ILMN

Illumina

$269.60 /

-25.695 (-8.70%)

UBS analyst Dan Brennan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

06:00 Today Stifel
Stifel downgrades Illumina to Hold after 'massively dilutive' deal
05:08 Today Stifel
Illumina downgraded to Hold from Buy at Stifel
05:02 Today Piper Sandler
Piper stays on sidelines after Illumina acquisition of Grail
09/21/20 JPMorgan
Illumina downgraded to Neutral after deal for Grail at JPMorgan
ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

ILMN Illumina
$269.60 /

-25.695 (-8.70%)

Recommendations
Accenture price target raised to $229 from $206 at Piper Sandler » 06:08
09/22/20
09/22
06:08
09/22/20
06:08
ACN

Accenture

$233.94 /

-2.17 (-0.92%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
09/21/20 Barclays
Accenture price target raised to $260 from $240 at Barclays
09/20/20 Citi
Accenture price target raised to $269 from $247 at Citi
09/17/20 Stifel
Accenture price target raised to $270 from $236 at Stifel
ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

ACN Accenture
$233.94 /

-2.17 (-0.92%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.